The ConsiGma™ high-shear granulation and drying concept is capable of producing pharmaceutical granules continuously, without start-up and shut-down waste. This concept enables the use of the same system for development and production work without the need for scale-up, as the determining factor for batch size is not the volume of the process vessel, but the running time. Scale-up has always been a very risky, time-consuming and costly exercise in tablet development and manufacturing. From now on, we can change the batch size without touching the process conditions.
Avoid upfront investment and preserve capital. GEA Financial Services offer to you attractive conditions to lease your new GEA equipment. Cost occur over time while the machine is used.
Video support designed to provide remote assistance in real-time.
Stay in touch with GEA innovations and stories by signing up for news from GEA.Sign up
We are here to help! With just a few details we will be able to respond to your inquiry.Contact us